The Dawn of a New Era: Cross-Border Collaborations—Regional, Pan-European, and Transcontinental—How Will They Shape the Future of Access?
Speaker(s)
Roisin Adams, MPharm, MSc., PhD, National Centre for Pharmacoeconomics, Dublin, Ireland & Discipline of Pharmacology and Therapeutics, Trinity College Dublin, Dublin, Ireland, Meindert Boysen, PharmD, MSc, Boysen Consulting International, London, England, UK, Johan Pontén, MA, Medicine Evaluation Committee (MEDEV), Stockholm, Sweden and Neil Grubert, MA, Independent, Basildon, ESS, UK
OVERVIEW: Neil Grubert (moderator) will begin with an overview of the key developments in cross-border collaboration in recent years. He will identify the key features of the leading regional, pan-European and transcontinental initiatives.
Dr Roisin Adams will reflect on the challenges and opportunities for regional partnerships, such as the Beneluxa Initiative and the International Horizon Scanning Initiative, and consider how they may evolve. She will also examine how the Heads of HTA Agencies will support voluntary cooperation on HTA.
Johan Potén will share insights on how the Nordic region has become a pioneer in cross-border collaboration, bringing together HTA and procurement to accelerate access to promising new treatments.
Dr Meindert Boysen will discuss the role the Novel Medicines Platform could play in improving access to innovative health technologies across Europe and beyond, and what other regions might learn. He will also consider how mature HTA agencies from different continents are working together in alliances such as the AUS-CAN-NZ-UK Collaboration Arrangement, and how they are helping less experienced countries to develop HTA systems.
Q&A
Code
311
Topic
Health Policy & Regulatory